Cargando…
Combining Radiotherapy and Immunotherapy in Definitive Treatment of Head and Neck Squamous Cell Carcinoma: Review of Current Clinical Trials
BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) presents as locally advanced disease in a majority of patients and is prone to relapse despite aggressive treatment. Since immune checkpoint inhibitors (ICI) have shown clinically significant efficacy in patients with recurrent/metastatic HNS...
Autores principales: | Plavc, Gaber, Strojan, Primoz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585335/ https://www.ncbi.nlm.nih.gov/pubmed/33064670 http://dx.doi.org/10.2478/raon-2020-0060 |
Ejemplares similares
-
Challenges in Combining Immunotherapy with Radiotherapy in Recurrent/Metastatic Head and Neck Cancer
por: Plavc, Gaber, et al.
Publicado: (2020) -
Influence of fat-free mass index on the survival of patients with head and neck cancer
por: Lapornik, Nina, et al.
Publicado: (2022) -
Mucosal melanoma of the head and neck: a population-based study from Slovenia, 1985-2013
por: Plavc, Gaber, et al.
Publicado: (2016) -
Post-radiation xerostomia therapy with allogeneic mesenchymal stromal stem cells in patients with head and neck cancer: study protocol for phase I clinical trial
por: Strojan, Primoz, et al.
Publicado: (2023) -
Impact of delays in radiotherapy of head and neck cancer on outcome
por: Žumer, Barbara, et al.
Publicado: (2020)